Skopos Labs, Inc. Olema Pharmaceuticals, Inc. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 18,915 shares of OLMA stock, worth $91,737. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,915Holding current value
$91,737% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding OLMA
# of Institutions
135Shares Held
64.3MCall Options Held
6.3KPut Options Held
15.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$33.2 Million8.64% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.74MShares$32.7 Million1.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$25.7 Million0.88% of portfolio
-
Black Rock Inc. New York, NY4MShares$19.4 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$16.7 Million0.45% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $196M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...